Chinese Patent Granted for Particle3D’s 3D printing technology
August 10th 2021, the China National Intellectual Property Administration (CNIPA) announced that Particle3D’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in China.
This marks Particle3D’s third patent issuance, following the approval and publication of its U.S. and European patents in 2020.
The patent covers the Company’s disruptive 3D printing technology which involves a novel formulation of biomaterials for 3D printing. In addition, the Chinese patent covers the use of metals and polymers.
The technology facilitates a new additive manufacturing process where medical implants are constructed directly from a computer-aided design (CAD) file. Particle3D will use this new way of 3D printing to enable the creation of P3D Bone – a unique, natural, and patient specific implant with controlled porosities – that allows for optimized bone ingrowth and a remodeling of the implant into real living bone.
The third patent issuance further supports Particle3D’s efforts to expand the high-potential P3D printing technology into new areas and industries. With unique customization of single units as well as cost effective mass customization, P3D printing allow businesses across various sectors to enhance their product development and manufacturing – while reducing costs.
Particle3D is a Danish MedTech company founded on proprietary technology to 3D print patient specific, natural, and resorbable bone implants. This enables fast ingrowth on bone tissue, remodeling into real living bone, and results in fewer complications. The technology is further used to provide 3D printed R&D products, develop implants with additives, such as antibiotics and other pharmaceuticals, and can even be used in industries outside healthcare. Website Particle3D – We Print Bone.
Phone: +45 5360 0670.